Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection Introducing chimeric antigen receptors into the endogenous T-cell receptor locus reduces tonic signalling, averts accelerated T-cell differentiation and delays T-cell exhaustion, leading to enhanced function and anti-tumour efficacy compared to random integrations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Springer Journals

Loading next page...
 
/lp/springer-journals/targeting-a-car-to-the-trac-locus-with-crispr-cas9-enhances-tumour-tOpXf0000V

References (34)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Subject
Science, Humanities and Social Sciences, multidisciplinary; Science, Humanities and Social Sciences, multidisciplinary; Science, multidisciplinary
ISSN
0028-0836
eISSN
1476-4687
DOI
10.1038/nature21405
Publisher site
See Article on Publisher Site

Abstract

Introducing chimeric antigen receptors into the endogenous T-cell receptor locus reduces tonic signalling, averts accelerated T-cell differentiation and delays T-cell exhaustion, leading to enhanced function and anti-tumour efficacy compared to random integrations.

Journal

NatureSpringer Journals

Published: Feb 22, 2017

There are no references for this article.